TrialJournal of diabetes research2022

A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.

Yingying Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.